Fate Therapeutics Inc logo

Fate Therapeutics Inc

$ 30.21 -2.69 (-8.18%) 11:09 PM EST
P/E:
At Loss
P/B:
5.31
Market Cap:
$ 2.93B
Enterprise V:
$ 2.73B
Volume:
1.28M
Avg Vol (2M):
1.55M
Also Trade In:
Volume:
1.28M
Market Cap $:
2.93B
PE Ratio:
At Loss
Avg Vol (2-Month):
1.55M
Enterprise Value $:
2.73B
PB Ratio:
5.31
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Fate Therapeutics Inc
NAICS : 325412 SIC : 2836
3535 General Atomics Court, Suite 200, San Diego, CA, USA, 92121
Description
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and immune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Financials (Next Earnings Date:2022-11-04 Est.)

FATE's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:FATE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 68.257
EPS (TTM) ($) -2.64
Beta 1.66
Volatility % 57.42
14-Day RSI 46.16
14-Day ATR ($) 2.822466
20-Day SMA ($) 32.342
12-1 Month Momentum % -62.46
52-Week Range ($) 17.1 - 91.9003
Shares Outstanding (Mil) 97

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Fate Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More